Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
|Articles|September 4, 2017
- August 2017 Pain Awareness
- Volume 83
- Issue 8
OTC Product News (August 2017)
Read about the OTC products featured in August.
Advertisement
MARKETED BY: The Mentholatum Company The Mentholatum Company has launched ROHTO DRY-AID, an OTC lubricant eye drop designed for patients who need an advanced artificial tear option to help relieve their dry-eye symptoms.
FOR MORE INFORMATION: rohtoeyedrops.com
MULTIVITAMIN ABDEKMARKETED BY: H2-Pharma H2-Pharma launched the MultiVitamin ABDEK family of vitamin offerings, specifically formulated for individuals with malabsorption conditions, such as cystic fibrosis, who have difficulty absorbing fat-soluble vitamins.
FOR MORE INFORMATION: H2-pharma.com
OLIVINOMARKETED BY: OlivinoLife OlivinoLife has launched a supplement combining non-GMO bioactive ingredients derived from Mediterranean diet staple foods including olives, grapes, and tomatoes.
FOR MORE INFORMATION: olivinolife.com
: Natrol Natrol introduced a new supplement, Natrol Cognium, for brain health. Backed by 9 human clinical studies, the active ingredient in Natrol Cognium has shown statistically significant improvement in memory and cognition in as little as 4 weeks.
FOR MORE INFORMATION: natrol.com
Articles in this issue
about 9 years ago
Generic Product News (August 2017)about 9 years ago
Intrarosaabout 9 years ago
Rx Product News (August 2017)about 9 years ago
ISMP Medication Error Safety Briefsabout 9 years ago
Self-Care for Painabout 9 years ago
Pharmacists Can Play Important Role in Depression Screeningabout 9 years ago
Balancing Prescription Safety and Costabout 9 years ago
Market Competition Levels May Influence Generic-Drug Costsabout 9 years ago
Cancer and Pain: Opportunities to Optimize Patient CareNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
SubscribeAdvertisement
Related to this article
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Intensive BP Control Cuts CV Risk Regardless of CKD Status
2
Pneumonic Plague: Symptoms, Antibiotics, and Current US Risk
3
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
4
Inside the New Consensus Recommendations for Acute Stroke Care
5